Update on the Angiotensin AT(2) Receptor

Overview

Journal Curr Hypertens Rep

Specialty Cardiology & Vascular Diseases

Date 2012 Dec 11

PMID 23224511

Citations 27

Authors

Claudia A McCarthy

Robert E Widdop

Kate M Denton

Emma S Jones

Affiliations

Soon will be listed here.

Abstract

It is quite well established that activation of the AT(2) receptor (AT(2)R) provides a counter-regulatory role to AT(1)R overactivity, particularly during pathological conditions. Indeed, a potential therapeutic role for the AT(2)R is currently being promulgated with the introduction of novel AT(2)R ligands such as compound 21 (C21). In this brief review, we will focus on recent evidence to suggest that AT(2)R exhibits promising organ protection in the context of the heart, kidney and brain, with inflammation and gender influencing outcome. However, this field is not without controversy since the 'flagship' ligand C21 has also come under scrutiny, although it is safe to say there is much evidence to support a potentially important role of AT(2)R in a number of cardiovascular diseases. This report updates recent data in this field.

Citing Articles

Oral Transfer of Anti-Aging Substances: Key Chemical Found in Reproductive Caste of Termites.

Peng X, Khan Z, Dong Y, Xing L Int J Mol Sci. 2025; 26(4).

PMID: 40004008 PMC: 11855088. DOI: 10.3390/ijms26041543.

Systematic-Narrative Hybrid Literature Review: Crosstalk between Gastrointestinal Renin-Angiotensin and Dopaminergic Systems in the Regulation of Intestinal Permeability by Tight Junctions.

Khan N, Kurnik-Lucka M, Latacz G, Gil K Int J Mol Sci. 2024; 25(10).

PMID: 38791603 PMC: 11122119. DOI: 10.3390/ijms25105566.

The role of the brain renin-angiotensin system in Parkinson´s disease.

Labandeira-Garcia J, Labandeira C, Guerra M, Rodriguez-Perez A Transl Neurodegener. 2024; 13(1):22.

PMID: 38622720 PMC: 11017622. DOI: 10.1186/s40035-024-00410-3.

Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson's Disease.

Angelopoulou E, Karlafti E, Georgakopoulou V, Papalexis P, Papageorgiou S, Tegos T Life (Basel). 2023; 13(2).

PMID: 36836893 PMC: 9961012. DOI: 10.3390/life13020536.

Association of Early and Supernormal Vascular Aging categories with cardiovascular disease in the Chinese population.

Cao Q, Li M, Wang T, Chen Y, Dai M, Zhang D Front Cardiovasc Med. 2022; 9:895792.

PMID: 36035913 PMC: 9403083. DOI: 10.3389/fcvm.2022.895792.

References

Matavelli L, Huang J, Siragy H . Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension. 2010; 57(2):308-13. PMC: 3060557. DOI: 10.1161/HYPERTENSIONAHA.110.164202. View

Padia S, Kemp B, Howell N, Fournie-Zaluski M, Roques B, Carey R . Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats. Hypertension. 2007; 51(2):460-5. DOI: 10.1161/HYPERTENSIONAHA.107.103242. View

Rosenstrom U, Skold C, Lindeberg G, Botros M, Nyberg F, Karlen A . A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II. J Med Chem. 2004; 47(4):859-70. DOI: 10.1021/jm030921v. View

Salomone L, Howell N, McGrath H, Kemp B, Keller S, Gildea J . Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism. Hypertension. 2006; 49(1):155-61. DOI: 10.1161/01.HYP.0000251881.89610.ee. View

Ocaranza M, Lavandero S, Jalil J, Moya J, Pinto M, Novoa U . Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro. J Hypertens. 2010; 28(5):1054-64. DOI: 10.1097/hjh.0b013e328335d291. View

Sampson A, Moritz K, Jones E, Flower R, Widdop R, Denton K . Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension. 2008; 52(4):666-71. DOI: 10.1161/HYPERTENSIONAHA.108.114058. View

Hilliard L, Nematbakhsh M, Kett M, Teichman E, Sampson A, Widdop R . Gender differences in pressure-natriuresis and renal autoregulation: role of the Angiotensin type 2 receptor. Hypertension. 2010; 57(2):275-82. DOI: 10.1161/HYPERTENSIONAHA.110.166827. View

Bosnyak S, Welungoda I, Hallberg A, Alterman M, Widdop R, JONES E . Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol. 2010; 159(3):709-16. PMC: 2828034. DOI: 10.1111/j.1476-5381.2009.00575.x. View

Henrion D, Kubis N, Levy B . Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension. 2001; 38(5):1150-7. DOI: 10.1161/hy1101.096109. View

10.

Flores-Munoz M, Smith N, Haggerty C, Milligan G, Nicklin S . Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor. J Physiol. 2010; 589(Pt 4):939-51. PMC: 3060371. DOI: 10.1113/jphysiol.2010.203075. View

11.

Jones E, Vinh A, McCarthy C, Gaspari T, Widdop R . AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther. 2008; 120(3):292-316. PMC: 7112668. DOI: 10.1016/j.pharmthera.2008.08.009. View

12.

Kaschina E, Unger T . Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 2003; 12(2):70-88. DOI: 10.1080/08037050310001057. View

13.

Horiuchi M, Iwanami J, Mogi M . Regulation of angiotensin II receptors beyond the classical pathway. Clin Sci (Lond). 2012; 123(4):193-203. DOI: 10.1042/CS20110677. View

14.

Paulis L, Becker S, Lucht K, Schwengel K, Slavic S, Kaschina E . Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling. Hypertension. 2012; 59(2):485-92. DOI: 10.1161/HYPERTENSIONAHA.111.185496. View

15.

Brown R, Hilliard L, Head G, Jones E, Widdop R, Denton K . Sex differences in the pressor and tubuloglomerular feedback response to angiotensin II. Hypertension. 2011; 59(1):129-35. DOI: 10.1161/HYPERTENSIONAHA.111.178715. View

16.

Walters P, Gaspari T, Widdop R . Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension. 2005; 45(5):960-6. DOI: 10.1161/01.HYP.0000160325.59323.b8. View

17.

Widdop R, Jones E, Hannan R, Gaspari T . Angiotensin AT2 receptors: cardiovascular hope or hype?. Br J Pharmacol. 2003; 140(5):809-24. PMC: 1574085. DOI: 10.1038/sj.bjp.0705448. View

18.

Henrion D . Why do we need a selective angiotensin II type 2 receptor agonist?. Hypertension. 2012; 60(3):616-7. DOI: 10.1161/HYPERTENSIONAHA.112.197046. View

19.

Li X, Widdop R . AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Br J Pharmacol. 2004; 142(5):821-30. PMC: 1575063. DOI: 10.1038/sj.bjp.0705838. View

20.

Wan Y, Wallinder C, Plouffe B, Beaudry H, Mahalingam A, Wu X . Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem. 2004; 47(24):5995-6008. DOI: 10.1021/jm049715t. View